AdvanCell
Operator of a radiopharmaceutical company intended for developing alpha therapies for cancer patients. The company develops alpha-emitting isotopes attached to molecules that deliver cytotoxic radiati...
Valuation
$0
Share Price
N/A
Total Raised
$132.3M
Last Round
N/A